Found: 9
Select item for more details and to access through your institution.
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.
- Published in:
- Oncogene, 2009, v. 28, n. 1, p. 85, doi. 10.1038/onc.2008.362
- By:
- Publication type:
- Article
Ligand internalization and recycling by human recombinant somatostatin type 4 (h sst<sub>4</sub>) receptors expressed in CHO-K1 cells.
- Published in:
- British Journal of Pharmacology, 2001, v. 132, n. 5, p. 1102, doi. 10.1038/sj.bjp.0703896
- By:
- Publication type:
- Article
NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.
- Published in:
- Oncogene, 2013, v. 32, n. 25, p. 3009, doi. 10.1038/onc.2012.453
- By:
- Publication type:
- Article
Beyond BRAF: where next for melanoma therapy?
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 2, p. 217, doi. 10.1038/bjc.2014.476
- By:
- Publication type:
- Article
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Integrating BRAF/MEK inhibitors into combination therapy for melanoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010.
- Published in:
- Pigment Cell & Melanoma Research, 2011, v. 24, n. 1, p. e1, doi. 10.1111/j.1755-148X.2010.00811.x
- By:
- Publication type:
- Article
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.
- Published in:
- 2007
- By:
- Publication type:
- journal article